The success of running and managing a clinical trial to assess the efficacy of a new treatment or device can largely be determined by how effectively it mirrors real-world outcomes.
In order to mirror the real world, it is vital that trial populations accurately reflect the real-world patient populations.
The diversity of trial participants remains an issue within the industry and having a diverse patient pool is key to the success of trials.
There has been growing pressure on companies to improve the diversity of their trial populations for decades, but work still needs to be done, including by regulators and ethics groups, who are increasingly taking action to bring about further progress in this area.
Check out the rest of this feature here
